Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
APPLICATION OF ALPHAVIRUS IN PREPARATION OF ANTITUMOR DRUGS
Document Type and Number:
Japanese Patent JP2019048863
Kind Code:
A
Abstract:
To provide a therapeutic agent for a human tumor, which is one or more of liver cancer, colorectal cancer, bladder cancer, breast cancer, cervical cancer, prostate cancer, glioma, melanoma, pancreatic cancer, nasopharyngeal carcinoma, lung cancer, or gastric cancer, and is a ZAP low expression or ZAP negative tumor, and an administration system therefor.SOLUTION: The present invention provides an antitumor drug comprising an alphavirus selected from an M1 virus having a gene sequence at least 97.8% identical to the M1 virus deposited under Accession No. CCTCC V201423, and a Getah virus, and a ZAP inhibitor which is a ZAP inhibitory antibody or ZAP inhibitory RNAi, and an administration system therefor.SELECTED DRAWING: None

Inventors:
YAN GUANGMEI
XIAO XIAO
HU JUN
LI KAI
LIANG JIANKAI
LIN YUAN
ZHANG HAIPENG
LIN SUIZHEN
Application Number:
JP2018218457A
Publication Date:
March 28, 2019
Filing Date:
November 21, 2018
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
GUANGZHOU VIROTECH PHARMACEUTICAL CO LTD
International Classes:
A61K35/76; A61K9/08; A61K9/20; A61K9/48; A61K9/70; A61K31/713; A61K39/395; A61P1/00; A61P1/16; A61P1/18; A61P11/00; A61P11/02; A61P11/04; A61P13/08; A61P13/10; A61P15/00; A61P17/00; A61P25/00; A61P35/00; A61P43/00; C07K14/47; C12N7/00; C12N15/113; C12Q1/6886
Domestic Patent References:
JP2010512141A2010-04-22
Other References:
CELL CYCLE, vol. 8, no. 20, JPN6017037547, 15 October 2009 (2009-10-15), pages 3328 - 3339, ISSN: 0004303909
BIOCHIMICA ET BIOPHYSICA ACTA, vol. 1842, JPN6017037549, 27 December 2013 (2013-12-27), pages 840 - 847, ISSN: 0004158006
PNAS, vol. 111, no. 42, JPN6017037544, 6 October 2014 (2014-10-06), pages 4504 - 4512, ISSN: 0004158007
Attorney, Agent or Firm:
sk patent corporation
Akihiko Okuno
Hiroyuki Ito